Revelation Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.00 (+0.00%)

As of Mar 29, 11:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +803.5% upside

Low Target $7.91

Average Target $10.21

High Target $15.75

Current Price $1.13

Current
$1.13

Target
$10.21

$7.91 $10.21 avg $15.75

Scenario Analysis

Bear Case

$7.91

600.0%

Low target

Base Case

$10.21

+803.5%

Avg target

Bull Case

$15.75

+1,293.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$44.76

-97.5% from high

52-Week Low

$1.12

+0.9% from low

Target vs 52W High

$10.21

-77.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%